JPMorgan Chase & Co’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,300
| Closed | -$116 | – | 6936 |
|
|
2023
Q3 | $116 | Sell |
1,300
-1,852
| -59% | -$165 | ﹤0.01% | 5936 |
|
|
2023
Q2 | $290 | Buy |
3,152
+1,852
| +142% | +$170 | ﹤0.01% | 5690 |
|
|
2023
Q1 | $0 | Hold |
1,300
| – | – | ﹤0.01% | 6410 |
|
|
2022
Q4 | $0 | Buy |
1,300
+250
| +24% | – | ﹤0.01% | 6324 |
|
|
2022
Q3 | $0 | Hold |
1,050
| – | – | ﹤0.01% | 6152 |
|
|
2022
Q2 | $1K | Hold |
1,050
| – | – | ﹤0.01% | 5548 |
|
|
2022
Q1 | $1K | Hold |
1,050
| – | – | ﹤0.01% | 5692 |
|
|
2021
Q4 | $1K | Hold |
1,050
| – | – | ﹤0.01% | 5674 |
|
|
2021
Q3 | $2K | Hold |
1,050
| – | – | ﹤0.01% | 5416 |
|
|
2021
Q2 | $2K | Sell |
1,050
-250
| -19% | -$476 | ﹤0.01% | 5391 |
|
|
2021
Q1 | $3K | Hold |
1,300
| – | – | ﹤0.01% | 5145 |
|
|
2020
Q4 | $3K | Hold |
1,300
| – | – | ﹤0.01% | 4779 |
|
|
2020
Q3 | $4K | Sell |
1,300
-150
| -10% | -$462 | ﹤0.01% | 4676 |
|
|
2020
Q2 | $6K | Buy |
1,450
+150
| +12% | +$621 | ﹤0.01% | 4555 |
|
|
2020
Q1 | $1K | Sell |
1,300
-5,955
| -82% | -$4.58K | ﹤0.01% | 4634 |
|
|
2019
Q4 | $9K | Buy |
7,255
+5,955
| +458% | +$7.39K | ﹤0.01% | 4515 |
|
|
2019
Q3 | $1K | Hold |
1,300
| – | – | ﹤0.01% | 4744 |
|
|
2019
Q2 | $1K | Hold |
1,300
| – | – | ﹤0.01% | 4804 |
|
|
2019
Q1 | $4K | Hold |
1,300
| – | – | ﹤0.01% | 4739 |
|
|
2018
Q4 | $3K | Buy |
1,300
+250
| +24% | +$577 | ﹤0.01% | 4755 |
|
|
2018
Q3 | $5K | Hold |
1,050
| – | – | ﹤0.01% | 4717 |
|
|
2018
Q2 | $5K | Buy |
+1,050
| New | +$5K | ﹤0.01% | 4668 |
|
|
2016
Q4 | – | Sell |
-136
| Closed | -$2K | – | 4626 |
|
|
2016
Q3 | $2K | Sell |
136
-1
| -0.7% | -$15 | ﹤0.01% | 4005 |
|
|
2016
Q2 | $1K | Buy |
+137
| New | +$1K | ﹤0.01% | 4208 |
|
|
2013
Q4 | – | Sell |
-87,294
| Closed | -$4.63M | – | 3861 |
|
|
2013
Q3 | $4.63M | Sell |
87,294
-11,131
| -11% | -$590K | ﹤0.01% | 2074 |
|
|
2013
Q2 | $5.26M | Buy |
+98,425
| New | +$5.26M | ﹤0.01% | 1931 |
|